Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lymphoma, Combination Chemotherapy Milestone

George Canellos

MD

🏢Dana-Farber Cancer Institute, Harvard Medical School🌐USA

Emeritus Professor of Medicine

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

George Canellos is a landmark figure in lymphoma oncology who established curative combination chemotherapy regimens for Hodgkin lymphoma, transforming it from a fatal disease to a curable one. He helped demonstrate the superiority of ABVD over MOPP for Hodgkin lymphoma, reducing long-term toxicity while maintaining high cure rates. His research has informed lymphoma treatment standards worldwide and contributed to the principles of combination chemotherapy that are universally applied in oncology. He is a founding figure of academic medical oncology.

Share:

🧪Research Fields 研究领域

MOPP chemotherapy
ABVD Hodgkin lymphoma
combination chemotherapy lymphoma
lymphoma curative therapy
hematologic oncology history

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 George Canellos 的研究动态

Follow George Canellos's research updates

留下邮箱,当我们发布与 George Canellos(Dana-Farber Cancer Institute, Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment